Home›Companies›Biotech & Pharma›Xanadu Bio

Xanadu Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 27, 2025·Suggest an edit

About Xanadu Bio

Xanadu Bio is a private company based in Gladwyne, Pennsylvania, incorporated in 2021 in Delaware. It has reported $22,999,980 raised in two offerings on Form D since December 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 13, 2025Aug 27, 2025$10,999,994fully sold4$2.7MEquity, Series B Preferred StockRule 506(b)Form D ↗
Aug 16, 2022Dec 27, 2022$11,999,986of $30.0M target8$1.4MEquity, Options, Series A Preferred StockRule 506(b)Form D ↗
Total, two offerings$22,999,980

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Xanadu Bio's Form D filed Aug 27, 2025.

TF
Taylor Feehley
Executive officer
MS
TW
Todd Wider
Executive officer, director and promoter
BT
Bruce Turner
Executive officer, director and promoter

Sources

  1. SECXanadu Bio, Inc. filing history